CrowdStrike Seeks Dismissal of Delta Lawsuit Over Contract Terms
CrowdStrike, a leading cybersecurity company, has filed a motion to dismiss a lawsuit brought against it by Delta …
April 12, 2021: -Wealthy countries have received the vast majority of the world’s supply of Covid-19 vaccine doses. In contrast, developing countries have received nearly 1%, the World Health Organization (WHO) says, at a press briefing on Friday.
Of the 700 million vaccine doses being distributed globally, “over 87% have gone up to high-income or upper- and middle-income countries, while low-income countries have got around 0.2%,” said Tedros Adhanom Ghebreyesus, director at WHO.
According to Tedros, 1 in 4 people in high-income countries has received a Covid-19 vaccine, in comparison to just 1 in above 500 in low-income countries. “There remains a shocking imbalance in the global distribution of vaccines,” said Tedros.
There is a shortage of coronavirus vaccine doses for COVAX, a global alliance that aims to provide developing nations with coronavirus vaccines, Tedros added.
“We understand that some countries and companies are planning their bilateral vaccine donations, bypassing COVAX for their commercial or political reasons,” Tedros said. “These bilateral arrangements are at the risk of fanning the flames of vaccine inequity.”
Tedros said COVAX partners—including WHO, the Coalition for Epidemic Preparedness Innovation, and Gavi, the Vaccine Alliance—are pursuing strategies to accelerate production and supply.
The alliance seeks donations from countries with surplus vaccine supply, expediting review of more vaccines, and discussing ways to expand global manufacturing capacity with several countries, Tedros and Gavi CEO Dr. Seth Berkley said.
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
CrowdStrike, a leading cybersecurity company, has filed a motion to dismiss a lawsuit brought against it by Delta …
Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Lacosamide Oral …
Major oil and gas companies are increasingly exploring opportunities to capitalize on the burgeoning demand for data center …
Bernstein, a prominent investment research firm, has expressed optimism about Eli Lilly, a leading pharmaceutical company. The firm believes …
Stellantis, a multinational automotive corporation, and Contemporary Amperex Technology Co. Limited (CATL), a leading global …
Bank of America has downgraded its Advanced Micro Devices (AMD) rating, citing concerns about potential market share losses …